| 1 |
Zhou Y, Wang H, Luo Y, Tuo B, Liu X, Li T. Effect of metabolism on the immune microenvironment of breast cancer. Biochim Biophys Acta Rev Cancer 2023;1878:188861. [PMID: 36813054 DOI: 10.1016/j.bbcan.2023.188861] [Reference Citation Analysis]
|
| 2 |
Dong K, Wei G, Sun H, Gu D, Liu J, Wang L. Metabolic crosstalk between thermogenic adipocyte and cancer cell: Dysfunction and therapeutics. Curr Opin Pharmacol 2023;68:102322. [PMID: 36502545 DOI: 10.1016/j.coph.2022.102322] [Reference Citation Analysis]
|
| 3 |
Rongrong Wu, Irene Yu, Yoshihisa Tokumaru, Mariko Asaoka, Masanori Oshi, Li Yan, Shujiro Okuda, Takashi Ishikawa, Kazuaki Takabe. Elevated bile acid metabolism and microbiome are associated with suppressed cell proliferation and better survival in breast cancer. Am J Cancer Res 2022;12. [PMID: 36504906] [Reference Citation Analysis]
|
| 4 |
Yang Y, Hou J, Liu J, Bhushan S, Wu G. The origins of resident macrophages in mammary gland influence the tumorigenesis of breast cancer. International Immunopharmacology 2022;110:109047. [DOI: 10.1016/j.intimp.2022.109047] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Yu X, Shi M, Wu Q, Wei W, Sun S, Zhu S. Identification of UCP1 and UCP2 as Potential Prognostic Markers in Breast Cancer: A Study Based on Immunohistochemical Analysis and Bioinformatics. Front Cell Dev Biol 2022;10:891731. [DOI: 10.3389/fcell.2022.891731] [Reference Citation Analysis]
|
| 6 |
Oshi M, Gandhi S, Yan L, Tokumaru Y, Wu R, Yamada A, Matsuyama R, Endo I, Takabe K. Abundance of reactive oxygen species (ROS) is associated with tumor aggressiveness, immune response, and worse survival in breast cancer. Breast Cancer Res Treat 2022;194:231-41. [PMID: 35639264 DOI: 10.1007/s10549-022-06633-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 7 |
Wang KK, He KY, Yang JY, Liu MJ, Guo JR, Liang JY, Wang JH, Xu ZX, Jian YP. Lactobacillus Suppresses Tumorigenesis of Oropharyngeal Cancer via Enhancing Anti-Tumor Immune Response. Front Cell Dev Biol 2022;10:842153. [PMID: 35300424 DOI: 10.3389/fcell.2022.842153] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Li P, Ren X, Zheng Y, Sun J, Ye G. Tumor promoting effect of circ_002172 associates with induced immune escape in breast cancer via the miR-296-5p/CXCL12 axis. Int Immunopharmacol 2022;106:108530. [PMID: 35240495 DOI: 10.1016/j.intimp.2022.108530] [Reference Citation Analysis]
|
| 9 |
Tokumaru Y, Oshi M, Huyser MR, Yan L, Fukada M, Matsuhashi N, Futamura M, Akao Y, Yoshida K, Takabe K. Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer. Sci Rep 2021;11:14134. [PMID: 34239017 DOI: 10.1038/s41598-021-93681-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
